Klassen Preston (CIK 1493056) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-27). Recent activity: Sell RGLS (115,555 shares), Buy RGLS (12,000 shares), Sell RGLS (31,445 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | President & Head of R & D | Sell | 115,555 | $0 |
| 2025-06-04 | Regulus Therapeutics Inc. (RGLS) | President & Head of R & D | Buy | 12,000 | $95,880 |
| 2025-01-15 | Regulus Therapeutics Inc. (RGLS) | President & Head of R & D | Sell | 31,445 | $39,621 |
Source: SEC Form 4 filings · as of 2025-06-27